RECK and neoplasm: A recent study reported that efficient knockdown of miR-21 by hierarchically tumor-activated nanoCRISPR-Cas13a (CHAIN) restored RECK expression and crippled downstream MMP-2, which undermined cancer proliferation, migration, and invasion in a hepatocellular carcinoma mouse model [59].